In Mouse Study, New Gel Therapy Stops Dangerous Brain Tumors
TUESDAY, April 25, 2023 (HealthDay News) — A gel applied directly into the brain could offer new hope for patients diagnosed with glioblastoma, the most common malignant brain tumor in adults.The gel cured 100% of lab mice with glioblastoma when it w…
Learn MoreHealth Highlights: April 25, 2023
New treatment could be safer way to fight brain tumors in kids. A more targeted form of radiation may be used to treat children with craniopharyngioma without causing learning problems later on, new research suggests. Read moreLots of U.S. seniors wou…
Learn MoreAnti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma
MONDAY, April 24, 2023 (HealthDay News) — For patients with advanced melanoma, treatment with anti-programmed cell death 1 (anti-PD-1) results in improved response rate and longer progression-free survival for those with normal vitamin D levels, acco…
Learn MoreCancer Risk Increased With Exposure to Four or More CT Scans by Age 18
MONDAY, April 24, 2023 (HealthDay News) — Exposure to four or more computed tomography (CT) scans before age 18 years is associated with increased risk of subsequent intracranial tumors, leukemia, and lymphoma, according to a study published online A…
Learn MoreFDA Approves Cord Blood Stem Cell Product for Blood Cancer Patients
MONDAY, April 24, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell therapy, to cut the risk of infection in patients with blood cancer followi…
Learn MoreMRI-Based AI Can Distinguish Aplastic Anemia From MDS
MONDAY, April 24, 2023 (HealthDay News) — A magnetic resonance imaging (MRI)-based machine learning method can distinguish aplastic anemia (AA) from myelodysplastic syndromes (MDS), according to a study published online March 6 in Clinical Radiology….
Learn MoreCombo Therapy May Prevent Cancer’s Return After Liver Surgery
MONDAY, April 24, 2023 (HealthDay News) — A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.The combo — atezolizumab (Tecentriq) and …
Learn MoreHow Many CT Scans Are Safe for Kids?
MONDAY, April 24, 2023 (HealthDay News) — Getting a single CT scan during childhood doesn’t appear to increase a child’s risk of a future brain tumor, leukemia or lymphoma, new research finds, but getting four or more scans more than doubles the chan…
Learn MoreHealth Highlights: April 24, 2023
Combo therapy may prevent cancer’s return after liver surgery. Atezolizumab and bevacizumab are already used together to treat advanced liver cancer, now a new study finds it does the same for early-stage disease. Read moreThis is your brain on books:…
Learn MoreHealth Highlights: April 21, 2023
Drug might delay onset of MS symptoms. When a brain scan reveals signs of multiple sclerosis and a patient has no symptoms of the autoimmune disease, doctors debate whether to monitor or treat for MS. A medication may slow onset of MS symptoms in the…
Learn More